skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [3];  [1];  [4];  [5];  [1]
  1. Department of Food Science and Nutrition, Kyungpook National University, 702-701 Daegu (Korea, Republic of)
  2. Bionutrigen, Konyang University, 302-911 Chungnam (Korea, Republic of)
  3. Cardiovascular Research Laboratory, Korea Research Institute of Bioscience and Biotechnology, Yusong, 305-333, Daejon (Korea, Republic of)
  4. Food and Bio-Industry Research Institute, Kyungpook National University, 702-701, Daegu (Korea, Republic of)
  5. Department of Genetic Engineering, Kyungpook National University, 702-701, Daegu (Korea, Republic of)

Two amide synthetic derivatives of 3,4-di(OH)-hydrocinnamate (HC), 3,4-dihydroxyphenylpropionic (L-serine methyl ester) amide (E030) and 3,4-dihydroxyphenylpropionic (L-aspartic acid) amide (E076), were investigated to compare their lipid-lowering efficacy with HC. Male rats were fed a 1 g/100 g high-cholesterol diet for 6 weeks with supplements of either clofibrate (0.02%, w/w), HC (0.025%, w/w), E030 (0.039%, w/w) or E076 (0.041%, w/w). The clofibrate supplement was used as a positive control for the lipid-lowering efficacy. The food intakes and body weight gains were not significantly different among the groups. The plasma and hepatic cholesterol and triglyceride levels were lower in clofibrate, HC, E030, and E076-supplemented groups compared to the control group. The supplementation of HC and its amide derivatives was as effective as clofibrate in increasing the ratio of HDL-cholesterol to total plasma cholesterol and reducing the atherogenic index (AI). The hepatic cholesterol level in the HC and E076 groups was significantly lower than that in the clofibrate group. The hepatic 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA reductase) and acyl-CoA:cholesterol acyltransferase (ACAT) activities were significantly lower in the all test groups than in the control group. The excretion of neutral sterol was significantly higher in the HC, E030, and E076-supplemented groups compared to the control group. The plasma AST and ALT activities, indirect indexes of hepatic toxicity, were significantly lower in the HC, E030, and E076-supplemented groups than in the control group. Accordingly, the current results suggest that E030 and E076, two amide synthetic derivatives of HC, are effective in lowering lipid activity.

OSTI ID:
20722003
Journal Information:
Toxicology and Applied Pharmacology, Vol. 208, Issue 1; Other Information: DOI: 10.1016/j.taap.2005.01.012; PII: S0041-008X(05)00035-9; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Effect of copper deficiency on rat hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase
Journal Article · Thu Feb 09 00:00:00 EST 1989 · FASEB Journal (Federation of American Societies for Experimental Biology); (USA) · OSTI ID:20722003

Pectin isolated from prickly pear (Opuntia SSP) modifies LDL metabolism in cholesterol-fed guinea pigs
Conference · Mon Feb 26 00:00:00 EST 1990 · FASEB Journal (Federation of American Societies for Experimental Biology); (United States) · OSTI ID:20722003

High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs
Journal Article · Fri Feb 01 00:00:00 EST 2013 · Toxicology and Applied Pharmacology · OSTI ID:20722003